Pharm2Market

@SDEE Member Spotlight: An interview with Mark Fortner, CEO Aspen Biosciences, launch of their new improved experience with Pharm2Market 2.0, Business Intel for #Biotech Communities and his SDEE member experience. SDEE Members: 10% off 1st month with SDEE21 code https://lnkd.in/gNS5MSV

Good Morning! A quick reminder: Don’t miss our roundtable discussion today at the American Strategic Portfolio Management in Life Sciences – West Coast conference! Topic: “Accelerating Drug Discovery with Integrated Program Management Solutions” ?? Thursday, January 30 | 3:00 PM – 3:45 PM In this session, we’ll explore how integrated tools can streamline planning, management, and execution across the drug discovery process. We’ll focus on key strategies for aligning research and development teams, optimizing handoffs, and utilizing cutting-edge tools and technologies to improve efficiency, communication, and project outcomes. This is an excellent opportunity for in-depth discussions and peer-to-peer learning in a collaborative setting. We look forward to seeing you there! #InnovationInPharma #PortfolioManagement #LifeSciences #DrugDiscovery #SDPM

Thank you to everyone who attended our presentation today at the American Strategic Portfolio Management in Life Sciences – West Coast conference! If you’re still in San Diego tomorrow, we’d love to see you at our roundtable discussion: Roundtable Topic: “Accelerating Drug Discovery with Integrated Program Management Solutions” ?? Thursday, January 30 | 3:00 PM – 3:45 PM This session will explore: The differences between research and development project management. Key practices for implementing research PM strategies. Aligning research and development teams for seamless handoffs. Tools and technologies to improve efficiency, communication, and alignment. Bring your experiences and challenges to this collaborative discussion. It’s an opportunity to share, learn, and gain actionable insights from peers in the field. We hope to see you there! #InnovationInPharma #PortfolioManagement #LifeSciences #DrugDiscovery #SDPM

Good Morning! Just a quick reminder: Our presentation at the American Strategic Portfolio Management in Life Sciences – West Coast conference is today! Join us for “Integration Path: Trends in Drug Discovery & Their Effects on PPM” ?? Wednesday, January 29 | 12:00 PM – 12:30 PM We’ll dive into emerging trends in AI, DNA-Encoded Libraries (DEL), and Targeted Protein Degraders (TPDs) and their impact on drug discovery and portfolio management. Looking forward to seeing you there! #InnovationInPharma #PortfolioManagement #LifeSciences #DrugDiscovery #SDPM

Discover the Future of Drug Discovery at ASPM Life Sciences – West Coast! Join Mark Fortner, CEO of Aspen Biosciences, as he presents “Integration Path: Trends in Drug Discovery & Their Effects on PPM” at the American Strategic Portfolio Management in Life Sciences – West Coast, happening in San Diego. Explore the transformative role of AI technologies, DNA-Encoded Libraries (DEL), and Targeted Protein Degraders (TPDs) in shaping the future of drug discovery. Gain insights into how these innovations are redefining planning, execution, and portfolio decision-making. Have questions or challenges? Bring your toughest problems—whether it’s redundancy, inefficiencies, or roadblocks—and discover actionable solutions at the cutting edge of science. Don’t miss this opportunity to stay ahead in a rapidly evolving industry. #InnovationInPharma #PortfolioManagement #LifeSciences #DrugDiscovery #SDPM0125

Haven’t registered yet? Now’s the perfect time! Take advantage of 50% off your registration with our discount code and join us at the American Strategic Portfolio Management in Life Sciences – West Coast conference. ?? Location: Embassy Suites by Hilton San Diego Bay-Downtown ?? Don’t miss out—register today! ?? Register here: https://bit.ly/3E89sy6 We look forward to connecting with you in San Diego! #InnovationInPharma #PortfolioManagement #LifeSciences #DrugDiscovery #SDPM

Mark Fortner, CEO of Aspen Biosciences, will be sharing his expertise at the American Strategic Portfolio Management in Life Sciences – West Coast next week in San Diego. Day 1 – Presentation “Integration Path: Trends in Drug Discovery & Their Effects on PPM” Discover how advancements like AI technologies, DNA-Encoded Libraries (DEL), and Targeted Protein Degraders (TPDs) are reshaping drug discovery. Mark will explore their impact on planning, execution, and portfolio strategies, offering actionable insights for research professionals. ?? Wednesday, January 29 | 12:00 PM – 12:30 PM Day 2 – Roundtable Discussion “Accelerating Drug Discovery with Integrated Program Management Solutions” Join Mark for an interactive discussion on integrating management tools to streamline processes and improve the transition from research to clinical trials. This session invites collaboration and the exchange of strategies to tackle challenges and enhance outcomes. ?? Thursday, January 30 | 3:00 PM – 3:45 PM For scientists and research project managers, these sessions are designed to provide practical guidance and innovative approaches to navigating the complexities of modern drug discovery. #InnovationInPharma #PortfolioManagement #LifeSciences #DrugDiscovery #SDPM0125

As we welcome 2025, we want to take a moment to thank you for your trust, support, and partnership over the past year. Your collaboration has been integral to our success, and we are truly grateful to be part of your journey and success. The New Year brings new opportunities, fresh beginnings, and the chance to achieve even greater things together. We are excited to continue building on the foundation we’ve created and helping you reach your goals. From all of us at Aspen Biosciences, we wish you a year filled with health, happiness, and prosperity. May 2025 bring you success in all your endeavors, both personal and professional. Cheers to an incredible year ahead!

As we close out a successful 2024, we want to extend our heartfelt thanks to our clients for their trust and partnership. We're excited to welcome 2025 with enthusiasm, continuing to help you streamline processes, eliminate bottlenecks, and empower scientists to focus on what truly matters. Wishing you all a joyful and prosperous New Year!

2024: Year In Review 2024 has been a year of exciting advancements at Aspen Biosciences, marked by the expansion of our Pipeline and PharmExchange platforms and the launch of innovative features designed to empower drug discovery efforts and to improve their capital efficiency. We’re thrilled to share some of the highlights: New Modules: New Features: Overall, these new modules ... https://bit.ly/4gR2nQm